BioSpace

Zealand pens up to $1.2B deal with Generate for AI-designed obesity, metabolic drugs

Obesity-focused Zealand Pharma is buying into Generate:Biomedicines’s generative AI platform to create new multispecific drug candidates.

By BioSpace

1 min read
Zealand pens up to $1.2B deal with Generate for AI-designed obesity, metabolic drugs
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights